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Background
Antimicrobial resistance has become a serious threat to
public health undermining the efficacy of existing antimi-
crobials (including the last-resort ones) while very few
novel antimicrobial agents are in the development pipe-
line. The interventions aimed to contain antimicrobial
resistance need a continuous surveillance of new mechan-
isms of resistance emergence and the spread of existing
ones. Romania participated since 2002 as member of Eur-
opean Antimicrobial Resistance Surveillance Network
(EARS) for invasive infection; it is a network which col-
lects data for the most important bacteria and clinically
relevant antibiotics. We analyzed the antimicrobial resis-
tance results obtained in 2012 in Romania, in order to
support national guidelines for antimicrobial treatment
and chemoprophylaxis.
Methods
Antimicrobial resistance data collected for EARS-Net in
10 public hospitals in Romania in 2012 (756 strains)
were analyzed; the resulting levels of resistance were
compared with the results from the previous year as
presented in EARS-Net 2011 report.
Results
The number of isolates was 2.55 folds greater than
in 2011. Resistance of enterococci to vancomycin is negli-
gible, together with Enterococcus faecalis resistance to
ampicillin. S pneumoniae non-susceptibility to penicillin
(38.6%), resistance to macrolides (39.5%) and dual (32.5%)
compromise these alternatives for invasive infection
treatment; the active options remain: third generation qui-
nolones and vancomycin (both with 100% susceptibility).
MRSA represent 53.5% of all isolates; TMP/SMX with
99.1% and vancomycin with 100% susceptibility had great-
est activity against S aureus. Escherichia coli resistance
increased for all antibiotics indicated in clinical use (also
as MDR – 15.7%) except for carbapenems, and showed a
stable increasing trend in last 4 years for quinolones, third
generation cephalosporins and aminoglycosides. Klebsiella
pneumoniae resistant to carbapenems had a sharp increase
in the last year (from 0% to 15%) and 42.7% of strains were
MDR. Resistance to carbapenems was high for non-
fermenters: Pseudomonas aeruginosa (61.4%) and Acineto-
bacter baumannii (86.3%); from tested antibiotics, only
colistin seems very active in vitro against non-fermenters,
but the results were derived from a few number of strains
(several laboratories didn’t test for colistin activity).
Conclusion
The antimicrobial resistance in 2012 reached great levels
for many antibiotics. There is an urgent need for a
national program and local interventions to stimulate the
rational use of antibiotics.
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